Axiomatic AI Funding drives the company’s mission to deliver verifiable engineering intelligence through physics-based.

Early prediction and identification of neurodegenerative diseases offers the best chance for prevention and treatment.

Leveraging expertise from leading research institutions, the company is developing the AI platform technical organizations will rely on to design, verify, and deploy complex hardware systems at scale.

Dental pulp regeneration remains a major clinical challenge. Researchers have discovered that SMAD7 directly forms a ...